dc.contributor.author
Solmi, Marco
dc.contributor.author
Cortese, Samuele
dc.contributor.author
Vita, Giovanni
dc.contributor.author
De Prisco, Michele
dc.contributor.author
Radua, Joaquim
dc.contributor.author
Dragioti, Elena
dc.contributor.author
Köhler-Forsberg, Ole
dc.contributor.author
Madsen, Nanna M.
dc.contributor.author
Rohde, Christopher
dc.contributor.author
Eudave, Luis
dc.contributor.author
Aymerich, Claudia
dc.contributor.author
Pedruzo, Borja
dc.contributor.author
Rodriguez, Victoria
dc.contributor.author
Rosson, Stella
dc.contributor.author
Sabé, Michel
dc.contributor.author
Hojlund, Mikkel
dc.contributor.author
Catalan, Ana
dc.contributor.author
de Luca, Beatrice
dc.contributor.author
Fornaro, Michele
dc.contributor.author
Ostuzzi, Giovanni
dc.contributor.author
Barbui, Corrado
dc.contributor.author
Salazar-de-Pablo, Gonzalo
dc.contributor.author
Fusar-Poli, Paolo
dc.contributor.author
Correll, Christoph U.
dc.date.accessioned
2025-10-09T16:10:47Z
dc.date.available
2025-10-09T16:10:47Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/49764
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-49488
dc.description.abstract
We aimed to identify diagnosis-specific/transdiagnostic/transoutcome multivariable candidate predictors (MCPs) of key outcomes in mental disorders. We conducted an umbrella review (protocol link), searching MEDLINE/Embase (19/07/2022), including systematic reviews of studies reporting on MCPs of response, remission, recovery, or relapse, in DSM/ICD-defined mental disorders. From published predictors, we filtered MCPs, validating MCP criteria. AMSTAR2/PROBAST measured quality/risk of bias of systematic reviews/individual studies. We included 117 systematic reviews, 403 studies, 299,888 individuals with mental disorders, testing 796 prediction models. Only 4.3%/1.2% of the systematic reviews/individual studies were at low risk of bias. The most frequently targeted outcome was remission (36.9%), the least frequent was recovery (2.5%). Studies mainly focused on depressive (39.4%), substance-use (17.9%), and schizophrenia-spectrum (11.9%) disorders. We identified numerous MCPs within disorders for response, remission and relapse, but none for recovery. Transdiagnostic MCPs of remission included lower disease-specific symptoms (disorders = 5), female sex/higher education (disorders = 3), and quality of life/functioning (disorders = 2). Transdiagnostic MCPs of relapse included higher disease-specific symptoms (disorders = 5), higher depressive symptoms (disorders = 3), and younger age/higher anxiety symptoms/global illness severity/ number of previous episodes/negative life events (disorders = 2). Finally, positive trans-outcome MCPs for depression included less negative life events/depressive symptoms (response, remission, less relapse), female sex (response, remission) and better functioning (response, less relapse); for schizophrenia, less positive symptoms/higher depressive symptoms (remission, less relapse); for substance use disorder, marital status/higher education (remission, less relapse). Male sex, younger age, more clinical symptoms and comorbid mental/physical symptoms/disorders were poor prognostic factors, while positive factors included social contacts and employment, absent negative life events, higher education, early access/intervention, lower disease-specific and comorbid mental and physical symptoms/conditions, across mental disorders. Current data limitations include high risk of bias of studies and extraction of single predictors from multivariable models. Identified MCPs can inform future development, validation or refinement of prediction models of key outcomes in mental disorders.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
mental disorders
en
dc.subject
Schizophrenia
en
dc.subject
quality of life
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1038/s41380-023-02298-3
dcterms.bibliographicCitation.journaltitle
Molecular Psychiatry
dcterms.bibliographicCitation.number
9
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
3671
dcterms.bibliographicCitation.pageend
3687
dcterms.bibliographicCitation.volume
28
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
37957292
dcterms.isPartOf.issn
1359-4184
dcterms.isPartOf.eissn
1476-5578